EJTCM

EJTCM European Journal of Translational and Clinical Medicine
open access journal published twice year
Edi

💡REVIEW ARTICLE💡⠀This   examines how type 2 diabetes increases the risk of atrial fibrillation by contributing to cardio...
18/05/2026

đź’ˇREVIEW ARTICLEđź’ˇ
â €
This examines how type 2 diabetes increases the risk of atrial fibrillation by contributing to cardiovascular damage and metabolic disturbances.
â €
â €
Check it out in the latest issue of
â €
â €
📍 https://ejtcm.gumed.edu.pl/articles/213788
â €
Current issue available:
https://ejtcm.gumed.edu.pl/issues/current
â €
â €
â €
â €

💡REVIEW ARTICLE💡⠀This review highlights ivonescimab—a novel bispecific antibody targeting PD-1 and VEGF-A as a promising...
04/05/2026

đź’ˇREVIEW ARTICLEđź’ˇ
â €
This review highlights ivonescimab—a novel bispecific antibody targeting PD-1 and VEGF-A as a promising, dual-action cancer therapy that boosts immune response and inhibits tumor blood vessel growth, showing strong clinical benefits in advanced non-small cell lung cancer.
â €
â €
Check it out in the latest issue of
â €
â €
📍 https://ejtcm.gumed.edu.pl/articles/213887
â €
Current issue available:
https://ejtcm.gumed.edu.pl/issues/current
â €
â €
â €
â €

💡REVIEW ARTICLE💡⠀This review highlights how CRISPR-Cas gene-editing technology is transforming modern medicine by offeri...
20/04/2026

đź’ˇREVIEW ARTICLEđź’ˇ
â €
This review highlights how CRISPR-Cas gene-editing technology is transforming modern medicine by offering powerful new therapeutic avenues for genetic, non-communicable, and infectious diseases while also addressing key challenges in safety and ethics.
â €
â €
Check it out in the latest issue of
â €
â €
📍https://ejtcm.gumed.edu.pl/articles/215857
â €
Current issue available:
https://ejtcm.gumed.edu.pl/issues/current
â €
â €
â €
â €

💡REVIEW ARTICLE💡⠀This literature review explores how specific microRNAs (miRNAs) could serve as non-invasive biomarkers ...
06/04/2026

đź’ˇREVIEW ARTICLEđź’ˇ
â €
This literature review explores how specific microRNAs (miRNAs) could serve as non-invasive biomarkers and potential therapeutic targets for predicting and understanding the development of long-term complications in diabetes mellitus.
â €
â €
Check it out in the latest issue of
â €
â €
📍 https://ejtcm.gumed.edu.pl/articles/209126
â €
Current issue available:
https://ejtcm.gumed.edu.pl/issues/current
â €
â €
â €
â €

💡REVIEW ARTICLE💡⠀This review outlines the complex challenges orthodontists face when treating patients who survived chil...
23/03/2026

đź’ˇREVIEW ARTICLEđź’ˇ
â €
This review outlines the complex challenges orthodontists face when treating patients who survived childhood cancer, highlighting how past oncologic therapies can disrupt craniofacial growth, dental development, and oral health, requiring adapted treatment strategies.
â €
â €
Check it out in the latest issue of
â €
â €
📍 https://ejtcm.gumed.edu.pl/articles/208477
â €
Current issue available:
https://ejtcm.gumed.edu.pl/issues/current
â €
â €
â €
â €

💡META-ANALYSIS💡⠀This   finds a strong association between the CTLA-4 genetic polymorphism and susceptibility to Graves’ ...
09/03/2026

đź’ˇMETA-ANALYSISđź’ˇ
â €
This finds a strong association between the CTLA-4 genetic polymorphism and susceptibility to Graves’ disease, suggesting this immune-regulation gene variant may play a key role in the autoimmune thyroid disorder.
â €
â €
Check it out in the latest issue of
â €
â €
📍 https://ejtcm.gumed.edu.pl/articles/208803
â €
Current issue available:
https://ejtcm.gumed.edu.pl/issues/current
â €
â €
â €
â €

💡RESEARCH ARTICLE💡⠀This research anatomically maps the length and location of septal papillary muscles in adult human he...
23/02/2026

đź’ˇRESEARCH ARTICLEđź’ˇ
â €
This research anatomically maps the length and location of septal papillary muscles in adult human hearts revealing significant variability that could impact cardiac imaging, surgery, and tricuspid valve function.
â €
â €
Check it out in the latest issue of
â €
â €
📍 https://ejtcm.gumed.edu.pl/articles/215153
â €
Current issue available:
https://ejtcm.gumed.edu.pl/issues/current
â €
â €
â €
â €

💡RESEARCH ARTICLE💡⠀This study shows that women with polycystic o***y syndrome (PCOS) have significantly higher serum dih...
09/02/2026

đź’ˇRESEARCH ARTICLEđź’ˇ
â €
This study shows that women with polycystic o***y syndrome (PCOS) have significantly higher serum dihydrotestosterone levels than healthy controls and suggests that DHT could serve as a highly accurate diagnostic biomarker for PCOS.
â €
â €
Check it out in the latest issue of
â €
â €
📍 https://ejtcm.gumed.edu.pl/articles/208403
â €
Current issue available:
https://ejtcm.gumed.edu.pl/issues/current
â €
â €
â €
â €

💡RESEARCH ARTICLE💡⠀This   investigates how fetal growth restriction relates to variations in fetal heart rate- measured ...
26/01/2026

đź’ˇRESEARCH ARTICLEđź’ˇ
â €
This investigates how fetal growth restriction relates to variations in fetal heart rate- measured non-invasively during pregnancy- to explore potential new markers for monitoring fetal well-being and growth.
â €
â €
Check it out in the latest issue of
â €
â €
📍 https://ejtcm.gumed.edu.pl/articles/208820
â €
Current issue available:
https://ejtcm.gumed.edu.pl/issues/current
â €
â €
â €
â €

💡INVITED EDITORIAL💡⠀This   highlights how heart disease- often underestimated by women who fear breast cancer most- rema...
12/01/2026

đź’ˇINVITED EDITORIALđź’ˇ
â €
This highlights how heart disease- often underestimated by women who fear breast cancer most- remains the leading killer worldwide, calling for better awareness, sex-specific risk recognition, and action against systemic bias in cardiovascular care.
â €
â €
Check it out in the latest issue of
â €
â €
📍 https://ejtcm.gumed.edu.pl/articles/208813
â €
Current issue available:
https://ejtcm.gumed.edu.pl/issues/current
â €
â €
â €
â €

Address


Alerts

Be the first to know and let us send you an email when EJTCM posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to EJTCM:

  • Want your business to be the top-listed Media Company?

Share